Acutus Medical, Inc.
AFIB · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | $7,139 | $5,266 | $4,127 | $3,625 |
| % Growth | 35.6% | 27.6% | 13.8% | – |
| Cost of Goods Sold | $6,125 | $4,894 | $4,470 | $3,655 |
| Gross Profit | $1,005 | $372 | -$343 | -$30 |
| % Margin | 14.1% | 7.1% | -8.3% | -0.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2,556 | $2,318 | $2,225 | $3,337 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$538 | -$2,435 | -$172 | $0 |
| Operating Expenses | $2,018 | -$117 | $2,053 | $3,337 |
| Operating Income | -$272 | $489 | $301 | -$575 |
| % Margin | -3.8% | 9.3% | 7.3% | -15.9% |
| Other Income/Exp. Net | -$1,031 | -$1,305 | -$663 | -$1,480 |
| Pre-Tax Income | -$1,303 | -$816 | -$362 | -$2,055 |
| Tax Expense | $0 | $4,791 | $0 | $0 |
| Net Income | -$1,406 | -$5,607 | -$914 | -$1,620 |
| % Margin | -19.7% | -106.5% | -22.1% | -44.7% |
| EPS | -0.047 | -0.19 | -0.031 | -0.055 |
| % Growth | 75.3% | -516.9% | 43.6% | – |
| EPS Diluted | -0.047 | -0.19 | -0.031 | -0.055 |
| Weighted Avg Shares Out | 29,768 | 29,799 | 29,722 | 29,694 |
| Weighted Avg Shares Out Dil | 29,768 | 29,799 | 29,722 | 29,694 |
| Supplemental Information | – | – | – | – |
| Interest Income | $122 | $153 | $207 | $281 |
| Interest Expense | $1,375 | $1,395 | $1,510 | $1,478 |
| Depreciation & Amortization | $250 | $257 | $256 | $264 |
| EBITDA | $322 | $836 | $1,404 | -$313 |
| % Margin | 4.5% | 15.9% | 34% | -8.6% |